<DOC>
	<DOCNO>NCT01313884</DOCNO>
	<brief_summary>The outcome patient metastatic Ewings Sarcoma poor current standard care chemotherapy , le 30 % survival . Based recent encourage pediatric literature design trial improve outcome patient metastatic Ewings sarcoma use Irinotecan Temozolomide addition standard chemotherapy .</brief_summary>
	<brief_title>Cyclophosphamide , Doxorubicin , Vincristine w/ Irinotecan Temozolomide Ewings Sarcoma</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Histologically cytologically confirm diagnosis metastatic Ewing 's sarcoma . Patients must measurable disease defined lesion measure medical image technique CT MRI . Ascites , pleural fluid , bone marrow disease , lesion see scan consider measurable . Patients must metastatic disease . Age 13 year old Life expectancy least 3 month . ECOG performance status &lt; = 3 . Normal hepatic function ( Direct bilirubin &lt; 1.5mg/dl , SGOT SGPT &lt; 3x upper limit normal ) . Left Ventricular Ejection fraction least 50 % . Adequate renal function : Creatinine clearance &gt; = 50 ml/min Serum creatinine &lt; 1.5 x ULN age . Adequate bone marrow reserve ( define absolute peripheral granulocyte count &gt; =1500/mm3 , platelet count &gt; =75,000/mm3 ) ; unless bone marrow infiltrate metastatic Ewing 's sarcoma ; ANC &gt; = 500 Platelet &gt; = 50,000 mm3 . Ability understand willing sign write informed consent document . Patients childbearing potential must agree use effective method contraception . No prior chemotherapy Ewing 's sarcoma ; No prior doxorubicin , temozolomide irinotecan . Known hypersensitivity component protocol drug . Clinically significant unrelated systemic illness ( serious infection require active systemic intravenous antibiotic therapy ; cardiovascular disease [ congestive heart failure , recent myocardial infarction , unstable angina , inadequately control hypertension ] . No prior history chronic diarrhea , bowel obstruction , Crohn 's disease ulcerative colitis . Pregnant nursing woman include study . HIVpositive patient exclude study due risk infection serious side effect . Other medical , psychiatric social condition incompatible study treatment .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>